Literature DB >> 22102371

Establishing a model organism: a report from the first annual Nematostella meeting.

Adam M Reitzel1, Joseph F Ryan, Ann M Tarrant.   

Abstract

The sea anemone Nematostella vectensis has developed into a model organism for studying genome evolution and animal development.
Copyright © 2012 WILEY Periodicals, Inc.

Entities:  

Mesh：

Year:  2011        PMID： 22102371     DOI： 10.1002/bies.201100145

Source DB:  PubMed          Journal:  Bioessays        ISSN： 0265-9247            Impact factor:   4.345


  5 in total

1.  Isolation of DNA, RNA and protein from the starlet sea anemone Nematostella vectensis.

Authors:  Derek J Stefanik; Francis S Wolenski; Lauren E Friedman; Thomas D Gilmore; John R Finnerty
Journal:  Nat Protoc       Date:  2013-04-11       Impact factor: 13.491

2.  Current directions and future perspectives from the third Nematostella research conference.

Authors:  Ann M Tarrant; Thomas D Gilmore; Adam M Reitzel; Oren Levy; Ulrich Technau; Mark Q Martindale
Journal:  Zoology (Jena)       Date:  2014-09-28       Impact factor: 2.240

3.  Collecting, rearing, spawning and inducing regeneration of the starlet sea anemone, Nematostella vectensis.

Authors:  Derek J Stefanik; Lauren E Friedman; John R Finnerty
Journal:  Nat Protoc       Date:  2013-04-11       Impact factor: 13.491

4.  Evolutionary profiling reveals the heterogeneous origins of classes of human disease genes: implications for modeling disease genetics in animals.

Authors:  Evan K Maxwell; Christine E Schnitzler; Paul Havlak; Nicholas H Putnam; Anh-Dao Nguyen; R Travis Moreland; Andreas D Baxevanis
Journal:  BMC Evol Biol       Date:  2014-10-04       Impact factor: 3.260

5.  Microbial diversity and activity in the Nematostella vectensis holobiont: insights from 16S rRNA gene sequencing, isolate genomes, and a pilot-scale survey of gene expression.

Authors:  Jia Y Har; Tim Helbig; Ju H Lim; Samodha C Fernando; Adam M Reitzel; Kevin Penn; Janelle R Thompson
Journal:  Front Microbiol       Date:  2015-09-02       Impact factor: 5.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.